Emerging Cell Therapies: A New Era of Regenerative Medicine (T9)
January 1-4, 2027
| Location to be Determined
Stefan Irion and Agnete Kirkeby
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
Saturday, January 2, 2027
| 8:00–9:00 AM |
Welcome and Keynote Address |
|
| |
Douglas A. Melton †, Vertex Pharmaceuticals
Treating T1D with PSC-Derived Islet Cells |
|
| 9:00–11:15 AM |
Bringing the Future Forward: Cell Therapies Proving Potential in Trials |
|
| |
Agnete Kirkeby, University of Copenhagen
Comprehensive Overview of the field of Cell Therapies |
|
| |
Jennifer Bahr-Davidson †, Lineage Cell Therapeutics
CMC Considerations for Late-Stage Clinical Development of OpRegen for dry AMD |
|
| |
Catherine Priest †, Neurona Therapeutics
NRTX-1001 Interneurons for Epilepsy |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 11:15–12:15 PM |
Panel Discussion 1: Funding Cell Therapies |
|
| 12:15–1:00 PM |
Poster Setup |
|
| 12:15–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Scanning the Horizon: The Next Generation of Cell Therapies Under Development |
|
| |
Ludovic Vallier †, Berlin Institute of Health at Charité
Therapy for Liver Disease |
|
| |
Stefan Irion, BlueRock Therapeutics
Cell Therapies for CNS Disease |
|
| |
Rob Coppes †, University Medical Center Groningen
Stem Cell Therapy for Radiation-Induced Hyposalivation |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Beyond the Cell: Building Multicellular Systems |
|
| |
Christopher S. Chen, Boston University
Vascularization of Multicellular Implants |
|
| |
Krishanu Saha †, University of Wisconsin-Madison
Engineering the Next Generation of Cell Therapies |
|
| |
Kelly R. Stevens †, University of Washington
Synthetic Human Tissues from Stem Cells |
|
| |
Holger Andreas Russ †, University of Florida and Tolerance Bio
Restoring Thymic Function to Induce Tolerance |
|
| |
Short Talk Chosen fro Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–12:00 PM |
Panel Discussion 2: The Second Valley of Death: How Cell Therapies can Survive in the Market Place |
|
| 11:00–1:00 PM |
Poster Setup |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 3:00–4:30 PM |
Career Roundtable |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Beyond the Tissue: The Realm of Whole Organ Transplantation |
|
| |
Adam W. Feinberg †, Carnegie Mellon University
Bioprinting the Human Heart |
|
| |
Jennifer A. Lewis †, Harvard University, SEAS
Engineering the Kidney |
|
| |
Wenning Qin †, eGenesis
Safe and Effective HuCo Organs for Xenotransplantation |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Engineering Tolerance: Designing for Immune Acceptance |
|
| |
Tobias Deuse †, University of California, San Francisco
Synthetic Immune Checkpoint Engagers to protect Allo-Grafts |
|
| |
Megan K. Levings †, University of British Columbia
Tregulatory Cells for Organ Transplantation |
|
| |
Vaneet Sandhu †, Fate Therapeutics
Clinical Trials for Autoimmune Disease |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–12:00 PM |
Panel Discussion 3: Preclinical Models: Human Cells in a Murine World: The Challenges of Testing Human Cells in Rodents |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–6:45 PM |
Engineering the Future: Cell and Tissue Therapies of Tomorrow |
|
| |
Patrick D. Hsu †, Arc Institute | University of California, Berkeley
Computational Mining to Identify Tools for Biological Programming |
|
| |
Charlotte Bunne †, École Polytechnique Fédérale de Lausanne
Large Language Models and the Virtual Cell to Advance Cellular Therapies |
|
| |
Katie Galloway †, Massachusetts Institute of Technology
Synthetic Biology Tools for Mammalian Cell Engineering |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions |
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
